CALCIMEDICA INC (CALC) Stock Overview
USA - NASDAQ:CALC - US38942Q2021 - Common Stock
CALC Key Statistics, Chart & Performance
The current stock price of CALC is 3.08 USD. In the past month the price increased by 12.82%. In the past year, price decreased by -27.36%.
CALC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 44.86 | 685.75B | ||
| JNJ | JOHNSON & JOHNSON | 17.97 | 432.80B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.15 | 247.10B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.97 | 239.37B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.61 | 228.69B | ||
| MRK | MERCK & CO. INC. | 10.2 | 196.23B | ||
| PFE | PFIZER INC | 7.01 | 135.09B | ||
| SNY | SANOFI-ADR | 10.21 | 111.07B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.56 | 89.80B | ||
| GSK | GSK PLC-SPON ADR | 8.86 | 80.28B | ||
| ZTS | ZOETIS INC | 23.07 | 63.60B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.83 | 46.55B |
Related stock screener links
About CALC
Company Profile
CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in La Jolla, California and currently employs 14 full-time employees. The company went IPO on 2020-09-25. The firm focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for inflammatory and immunologic diseases. The firm's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The firm is conducting a Phase IIb trial (called CARPO) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase I/II asparaginase-induced pancreatic toxicity (AIPT) study (called CRSPA).
Company Info
CALCIMEDICA INC
505 Coast Boulevard South, Suite 307
La Jolla CALIFORNIA US
Employees: 15
Phone: 18589525500
CALCIMEDICA INC / CALC FAQ
What is the stock price of CALCIMEDICA INC today?
The current stock price of CALC is 3.08 USD. The price increased by 2.33% in the last trading session.
What is the ticker symbol for CALCIMEDICA INC stock?
The exchange symbol of CALCIMEDICA INC is CALC and it is listed on the Nasdaq exchange.
On which exchange is CALC stock listed?
CALC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CALCIMEDICA INC stock?
10 analysts have analysed CALC and the average price target is 16.32 USD. This implies a price increase of 429.87% is expected in the next year compared to the current price of 3.08. Check the CALCIMEDICA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CALCIMEDICA INC worth?
CALCIMEDICA INC (CALC) has a market capitalization of 43.03M USD. This makes CALC a Nano Cap stock.
How many employees does CALCIMEDICA INC have?
CALCIMEDICA INC (CALC) currently has 15 employees.
What are the support and resistance levels for CALCIMEDICA INC (CALC) stock?
CALCIMEDICA INC (CALC) has a support level at 3.07 and a resistance level at 3.1. Check the full technical report for a detailed analysis of CALC support and resistance levels.
Should I buy CALCIMEDICA INC (CALC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CALC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CALC, evaluating the profitability, health, valuation and growth aspects
- CALCIMEDICA INC (CALC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CALCIMEDICA INC (CALC) Sales and EPS estimates to see what analysts future expectations are.
- CALCIMEDICA INC (CALC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CALCIMEDICA INC (CALC) Insider and Institutional Ownership to learn about the owners and their transactions.
- CALCIMEDICA INC (CALC) Stock Chart to make your own analysis
- CALCIMEDICA INC (CALC) Latest news and press-releases to stay up to date.
Does CALCIMEDICA INC (CALC) stock pay dividends?
CALC does not pay a dividend.
When does CALCIMEDICA INC (CALC) report earnings?
CALCIMEDICA INC (CALC) will report earnings on 2025-11-11, after the market close.
What is the Price/Earnings (PE) ratio of CALCIMEDICA INC (CALC)?
CALCIMEDICA INC (CALC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.64).
What is the Short Interest ratio of CALCIMEDICA INC (CALC) stock?
The outstanding short interest for CALCIMEDICA INC (CALC) is 0.54% of its float. Check the ownership tab for more information on the CALC short interest.
CALC Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CALC. When comparing the yearly performance of all stocks, CALC is one of the better performing stocks in the market, outperforming 90.21% of all stocks.
CALC Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CALC. Both the profitability and financial health of CALC have multiple concerns.
CALC Financial Highlights
Over the last trailing twelve months CALC reported a non-GAAP Earnings per Share(EPS) of -1.64. The EPS decreased by -17.14% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -74.45% | ||
| ROE | -173.33% | ||
| Debt/Equity | 0.79 |
CALC Forecast & Estimates
10 analysts have analysed CALC and the average price target is 16.32 USD. This implies a price increase of 429.87% is expected in the next year compared to the current price of 3.08.